Catch up before the revival arrives.

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced Dr.

Victoria Craig When it comes to how the US behaves, the Supreme Court struck down the IEEPA-based tariffs, and that was seen ...

Performers, poets, artists and artisans came together for an emotionally charged evening of protest and peace in Flossmoor.

With just two years left, the 2028 Super Bowl in Atlanta lacks a set date, sparking concerns about planning and execution.

BBC Sport breaks down the main storylines and talking points as the Championship enters the final section of the 2025-26 ...

For millions, renting isn't a temporary step or a marker of failure. It's how to secure proximity to opportunity and a safe ...

AT COLLECTED WORKS. Collected Works is hosting three author events this week. The first one features oral historian Garrett M ...

One of the most recognisable buildings in all of Newcastle is nearing its 250th anniversary with some big plans in place ...

What if the Padres had finished off the Dodgers in 2024? Inside the NLDS collapse that sparked Los Angeles’ dynasty and ...

Novel immunotherapeutics have transformed oncology, moving away from broad, non-specific treatments toward highly ...